Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit

Critical Care Medicine

Volumn 37, Issue 5, 2009, Pages 1605-1611

  Croda, Julio ^a,b   Croda, Mariana Garcia ^c   Neves, Alan ^a   De Sousa Dos Santos, Sigrid ^a  

^a Infectious and Parasitic Diseases Division   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c Emilio Ribas Infectious Diseases Institute   (Brazil)

Author keywords

Acquired immunodeficiency syndrome; Antiretroviral therapy; Critical care; Human immunodeficiency virus; Intensive care; Mortality; Prognostic factors

Indexed keywords

PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; ZIDOVUDINE;

ACUTE PANCREATITIS; ADULT; ANEMIA; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL FEATURE; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HEMATOLOGIC DISEASE; HOSPITAL ADMISSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE UNIT; LACTIC ACIDOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PANCREATITIS; PRIORITY JOURNAL; PROGNOSIS; SEPSIS; TERTIARY HEALTH CARE; TREATMENT OUTCOME;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BRAZIL; COHORT STUDIES; CONFIDENCE INTERVALS; CRITICAL CARE; CRITICAL ILLNESS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL ANALYSIS;

EID: 67650508781     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e31819da8c7     Document Type: Article

References (35)

1. Kaplan JE, Hanson D, Dworkin MS, et al: Epidemiology of human immunodeficiency virus-associated opportunistic infections in the United States in the era of highly active antiretroviral therapy. Clin Infect Dis 2000; 30 (Suppl 1):S5-S14
2. Moore RD, Chaisson RE: Natural history of HIV infection in the era of combination an-tiretroviral therapy. Aids 1999; 13:1933-1942
3. Palella FJ Jr, Delaney KM, Moorman AC, et al: Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998; 338: 853-860
4. Moore RD, Chaisson RE: Natural history of opportunistic disease in an HIV-infected urban clinical cohort. Ann Intern Med 1996; 124:633-642
5. Narasimhan M, Posner AJ, DePalo VA, et al: Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest 2004; 125:1800-1804
6. Morris A, Creasman J, Turner J, et al: Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 2002; 166:262-267
7. Afessa B, Green B: Clinical course, prognostic factors, and outcome prediction for HIV patients in the ICU. The PIP (Pulmonary complications, ICU support, and prognostic factors in hospitalized patients with HIV) study. Chest 2000; 118:138-145
8. Casalino E, Wolff M, Ravaud P, et al: Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. Aids 2004; 18: 1429-1433
9. Huang L, Quartin A, Jones D, et al: Intensive care of patients with HIV infection. N Engl J Med 2006; 355:173-181
10. Nuesch R, Geigy N, Schaedler E, et al: Effect of highly active antiretroviral therapy on hospitalization characteristics of HIV-infected patients. Eur J Clin Microbiol Infect Dis 2002; 21:684-687
11. Palacios R, Hidalgo A, Reina C, et al: Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit. HIV Med 2006; 7:193-196
12. Boumis E, Petrosillo N, Girardi E, et al: Changing patterns in the etiology of HIV-associated bacterial pneumonia in the era of highly active antiretroviral therapy. Eur J Clin Microbiol Infect Dis 2001; 20:71-73
13. Alves C, Nicolas JM, Miro JM, et al: Reappraisal of the aetiology and prognostic factors of severe acute respiratory failure in HIV patients. Eur Respir J 2001; 17:87-93
14. Vincent B, Timsit JF, Auburtin M, et al: Characteristics and outcomes of HIV-infected patients in the ICU: Impact of the highly active antiretroviral treatment era. Intensive Care Med 2004; 30:859-866
15. Rosenberg AL, Seneff MG, Atiyeh L, et al: The importance of bacterial sepsis in intensive care unit patients with acquired immunodeficiency syndrome: Implications for future care in the age of increasing antiretroviral resistance. Crit Care Med 2001; 29:548-556
16. Mrus JM, Braun L, Yi MS, et al: Impact of HIV/AIDS on care and outcomes of severe sepsis. Crit Care 2005; 9:R623-R630
17. Morris A, Wachter RM, Luce J, et al: Improved survival with highly active antiretro-viral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia. Aids 2003; 17:73-80
18. Vargas-Infante YA, Guerrero ML, Ruiz-Palacios GM, et al: Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit. Arch Med Res 2007; 38:827-833
19. Casalino E, Mendoza-Sassi G, Wolff M, et al: Predictors of short- and long-term survival in HIV-infected patients admitted to the ICU. Chest 1998; 113:421-429
20. Nickas G, Wachter RM: Outcomes of intensive care for patients with human immunodeficiency virus infection. Arch Intern Med 2000; 160:541-547
21. Bedos JP, Dumoulin JL, Gachot B, et al: Pneumocystis carinii pneumonia requiring intensive care management: Survival and prognostic study in 110 patients with human immunodeficiency virus. Crit Care Med 1999; 27:1109-1115
22. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep 1987; 36 (Suppl 1):1S-15S.
23. Heyland DK, Tougas G, King D, et al: Impaired gastric emptying in mechanically ventilated, critically ill patients. Intensive Care Med 1996; 22:1339-1344
24. Tarling MM, Toner CC, Withington PS, et al: A model of gastric emptying using paracetamol absorption in intensive care patients. Intensive Care Med 1997; 23:256-260
25. Battegay M, Nuesch R, Hirschel B, et al: Immunological recovery and antiretroviral therapy in HIV-1 infection. Lancet Infect Dis 2006; 6:280-287
26. Wit FW, Weverling GJ, Weel J, et al: Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy. J Infect Dis 2002; 186:23-31
27. Sulkowski MS, Mehta SH, Chaisson RE, et al: Hepatotoxicity associated with protease inhibitor-based antiretroviral regimens with or without concurrent ritonavir. Aids 2004; 18: 2277-2284
28. Bonnet F, Bonarek M, Abridj A, et al: [Severe lactic acidosis in HIV-infected patients treated with nucleosidic reverse transcrip-tase analogs: A report of 9 cases]. Rev Med Interne 2003; 24:11-16
29. Zolopa A, Andersen J, Komarow L, et al: Immediate vs deferred ART in the setting of acute AIDS-related opportunistic infection: Final results of a randomized strategy trial, ACTG A5164. In: 15th Conference on Retro-viruses and Opportunistic Infections, Boston, MA, 2008
30. Thyrault M, Gachot B, Chastang C, et al: Septic shock in patients with the acquired immunodeficiency syndrome. Intensive Care Med 1997; 23:1018-1023
31. De Palo VA, Millstein BH, Mayo PH, et al: Outcome of intensive care in patients with HIV infection. Chest 1995; 107:506-510
32. Afessa B, Morales I, Weaver B: Bacteremia in hospitalized patients with human immunodeficiency virus: A prospective, cohort study. BMC Infect Dis 2001; 1:13
33. Afessa B, Green B: Bacterial pneumonia in hospitalized patients with HIV infection: The Pulmonary Complications, ICU Support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest 2000; 117: 1017-1022
34. Timsit JF: Open the intensive care unit doors to HIV-infected patients with sepsis. Crit Care 2005; 9:629-630
35. CN-DST/AIDS: Boletim Epidemiológico - Aids e DST. In: Aids MdS-SdVeS-PNdDe (Eds), 2005, pp 48